Gabapentin for Anxiety: What Patients Should Know Before Considering It

Gabapentin is an anticonvulsant medication originally developed to treat seizures. Over time, its use has expanded to other conditions involving nerve pain and neurological dysfunction. The U.S. Food and Drug Administration (FDA) has approved gabapentin for:

• Partial seizures in adults and children (as an add-on therapy)
• Postherpetic neuralgia, a type of nerve pain that can occur after shingles
• Restless legs syndrome (in its extended-release form)

Beyond its FDA-approved uses, gabapentin is sometimes prescribed off-label for conditions such as migraine prevention, fibromyalgia, hot flashes, and anxiety disorders.

Gabapentin has become a popular topic in mental health forums and even Reddit online discussions around anxiety treatments. There are a few reasons for this:

• It’s not an SSRI or benzodiazepine, which appeals to people wary of antidepressants or habit-forming medications—despite gabapentin’s own demonstrated misuse potential.
• Word of mouth and anecdotal reports—especially online—often highlight its calming effects, even in the absence of robust research.

A 2017 research study noted that gabapentin is “increasingly being used to treat generalized anxiety disorder (GAD),” though it also cautioned that “little is known about its effectiveness.”

Gabapentin’s evidence base for anxiety is limited and context-specific:

• Some small studies suggest benefits for social anxiety disorder (SAD) or public speaking anxiety, showing reduced symptoms in controlled settings.
• In panic disorder, gabapentin may help in more severe cases but is not broadly effective.
• For generalized anxiety disorder (GAD), the evidence is sparse and inconsistent, with limited support from randomized clinical trials.

While these findings are intriguing, they fall short of the standards typically required for first-line treatment recommendations.

In my clinical experience, gabapentin is not a go-to option for anxiety. It may be considered in specific scenarios, particularly when:

• The individual has not responded to first-line treatments like SSRIs or SNRIs
• Augmentation strategies with medications like buspirone or low-dose atypical antipsychotics have been tried without success
• There are significant concerns about side effects or tolerability with standard medications

Even then, it is generally used as an add-on treatment rather than a primary intervention.

Gabapentin is not suitable for everyone. It should only be taken as and when prescribed and should generally be avoided in:

• People with impaired kidney function, as the drug is excreted through the kidneys and can accumulate in the body
• Individuals in alertness-critical professions, such as teachers, drivers, or machine operators, due to its sedating properties
• Those with a history of substance use disorders, because gabapentin has demonstrated misuse potential and is a controlled substance in some states

Common side effects include:

• Drowsiness or fatigue
• Dizziness or balance issues
• Cognitive dulling or slowed thinking

Less commonly, gabapentin may contribute to:

• Mood changes, including depression or irritability
• Withdrawal symptoms if stopped abruptly
• Respiratory depression, especially when combined with other CNS depressants

These risks underscore the importance of medical supervision and individualized treatment planning.

When compared to gold-standard anxiety treatments like SSRIs and SNRIs, gabapentin falls short:

• SSRIs/SNRIs have extensive, high-quality research supporting their efficacy and safety
• They are typically dosed once daily, promoting better adherence
• Side effects are often more predictable and manageable

Gabapentin often requires multiple daily doses, has a higher sedative burden, and lacks long-term data in anxiety populations. While it may help in isolated, resistant cases, it should not replace first-line options.

Gabapentin for anxiety is best viewed as a niche tool—potentially helpful in certain complex, treatment-resistant situations but not a front-line solution. It is not FDA-approved for this use, and its evidence base is limited. If you’re considering gabapentin, it’s essential to do so under the guidance of a qualified mental health provider who understands the full clinical picture.

Need Support? If you’re exploring alternatives to SSRIs or struggling with anxiety that hasn’t responded to treatment, schedule an appointment with a psychiatric clinician. A personalized, evidence-informed approach is key to finding what works best for you.